🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSemaglutide cardiovascular benefit independent of weight loss — March 2026 Page 2

Semaglutide cardiovascular benefit independent of weight loss — March 2026

KevinCompounds Wed, Sep 11, 2024 at 8:02 PM 50 replies 2,983 viewsPage 2 of 10
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Sep 11, 2024 at 9:37 PM#6
Dr.AddMedPHL said:
The mechanism that matters here is not stomach emptying, it is central.

Pushing back on Dr.AddMedPHL here. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

That is the short version; the long version is somebody else's post.

20 15LeilaHI, marcus_mpls, DeniseRN_TPA and 17 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Sep 11, 2024 at 10:14 PM#7

One concrete data point for the thread. For anyone assembling their own picture: Tmax is one to three days, terminal half-life about 165 to 170 hours, steady state at four to five weeks, and subcutaneous bioavailability near 89%. Those four numbers explain most of the questions people ask about timing.

19 14NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 16 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Sep 11, 2024 at 10:51 PM#8
MikeFit_NJ said:
The "earlier than weight loss explains" argument is weaker than this thread makes it sound.

Adding the part of the answer the thread has not reached. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

That is the short version; the long version is somebody else's post.

18 13MikeFit_NJ, InsuranceTom, WendyG_ATL and 15 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
patPC_UT
Member
212
890
Nov 2024
Park City, UT
Sep 11, 2024 at 11:28 PM#9

A narrower follow-up, since the general answer is now clear:

Whether anyone has held at a sub-maximal dose long term and kept the result, or whether the maintenance data only exists at 2.4mg?

17 12JessicaM_2024, TomFromTexas, mike.trainer_LA and 14 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Sep 12, 2024 at 2:24 AM#10

OP back with an update, since a thread like this is useless without one.

Update since I posted: I held at 1.7mg for a further twelve weeks and lost another 4kg slowly, which settles it for me. I was escalating because the number was available, not because I had stopped responding.

1 24NurseAsh_DET
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register